Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
July 22, 2015
Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists
Elizabeth H Baldini, Ross A Abrams, Walter Bosch, et al.
Journal of the National Cancer Institute
|
October 19, 2014
Combining targeted agents with modern radiotherapy in soft tissue sarcomas
Philip Wong, Peter Houghton, David G Kirsch, et al.
The Journal of Experimental Medicine
|
October 6, 2005
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
Luca Gattinoni, Steven E Finkelstein, Christopher A Klebanoff, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 2011
Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists
Dian Wang, Walter Bosch, David G Kirsch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 22, 2016
The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
John M Stahl, Rudi Ross, Eileen M Harder, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2004
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells
Christopher A Klebanoff, Steven E Finkelstein, Deborah R Surman, et al.
Journal of Leukocyte Biology
|
May 25, 2004
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer
Steven E Finkelstein, David M Heimann, Christopher A Klebanoff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 5, 2008
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity
Douglas C Palmer, Chi-Chao Chan, Luca Gattinoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2015
Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial
Dian Wang, Qiang Zhang, Burton L Eisenberg, et al.
The Lancet. Oncology
|
October 3, 2024
Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO)
Zachary S Zumsteg, Siddharth Sheth, Salma K Jabbour, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
International Journal of Radiation Oncology, Biology, Physics
|
July 22, 2015
Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists
Elizabeth H Baldini, Ross A Abrams, Walter Bosch, et al.
Journal of the National Cancer Institute
|
October 19, 2014
Combining targeted agents with modern radiotherapy in soft tissue sarcomas
Philip Wong, Peter Houghton, David G Kirsch, et al.
The Journal of Experimental Medicine
|
October 6, 2005
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
Luca Gattinoni, Steven E Finkelstein, Christopher A Klebanoff, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 2011
Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists
Dian Wang, Walter Bosch, David G Kirsch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 22, 2016
The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
John M Stahl, Rudi Ross, Eileen M Harder, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2004
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells
Christopher A Klebanoff, Steven E Finkelstein, Deborah R Surman, et al.
Journal of Leukocyte Biology
|
May 25, 2004
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer
Steven E Finkelstein, David M Heimann, Christopher A Klebanoff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 5, 2008
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity
Douglas C Palmer, Chi-Chao Chan, Luca Gattinoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2015
Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial
Dian Wang, Qiang Zhang, Burton L Eisenberg, et al.
The Lancet. Oncology
|
October 3, 2024
Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO)
Zachary S Zumsteg, Siddharth Sheth, Salma K Jabbour, et al.
Page
of 7